Aglaia
Aglaia · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Aglaia is a diverse genus of plants that has gained significant scientific interest due to its potent bioactive properties. The genus is particularly noted for producing unique chemical compounds known as rocaglamides, including rocaglaol and rocaglamide A. These specific phytochemicals exhibit remarkable anticancer and cytoprotective activities in various biological models. Extensive research suggests these substances hold therapeutic potential against several malignancies, such as acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Consequently, Aglaia remains a vital subject of study in the ongoing search for novel cancer treatments.
- Synonyms
- Oraoma · Nialel · 11 more
- Common names
- Not available
- Family
- Meliaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Aglaia is a diverse genus of flowering plants known by several different names across various linguistic traditions. In English-speaking contexts, it is frequently referred to by its transliterated common names, aglaja or aglája. The plant also holds specific designations in Cyrillic script, where it is identified as Аглайя. Moving into East Asian botanical classifications, the genus is recognized by its Chinese names, 樹蘭屬 and 米仔兰属. This variety of nomenclature highlights the widespread global presence and cultural significance of these botanical specimens.
Sources: Catalogue of Life (COL)
Synonyms
Aglaia is a diverse genus that has historically been subject to various taxonomic reclassifications. Over time, several distinct names have been identified as synonyms within this botanical group. These include established names such as Aglaiopsis and Amoora, which are now integrated into its classification. Furthermore, the genus has also been linked to the synonyms Argophilum, Beddomea, and Camunium. Understanding these shifting relationships is essential for maintaining accurate botanical records and clarity in plant studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aglaia is a fascinating plant that belongs to the diverse kingdom Plantae. Within this vast group, it is specifically classified under the class Equisetopsida. Its taxonomic journey continues through the order Sapindales, which helps define its evolutionary lineage. More closely, the plant is a member of the Meliaceae family, a group known for its distinct botanical characteristics. Ultimately, it is identified by its own unique genus, Aglaia, which distinguishes it from other related species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Meliaceae |
| Genus | Aglaia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aglaia exhibits a widespread distribution across various temperate regions of Asia. Within China, this genus can be found in diverse locales ranging from the South-Central provinces to the Southeast. Its presence extends to specialized environments such as the island of Hainan and the high-altitude regions of Tibet. Furthermore, the plant is commonly documented throughout Eastern Asia, specifically within Taiwan. This broad geographic range highlights the adaptability of the genus across different Asian landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Aglaia, a genus of medicinal plants found in Southeast Asia, serves as a vital source of complex natural products known as flavaglines. These compounds have demonstrated exceptional anticancer activity by targeting essential proteins such as prohibitins and the helicase eIF4A to inhibit tumor cell progression. Beyond their ability to fight malignancy, these derivatives also exhibit significant cytoprotective properties that may benefit various biological systems. Specifically, research indicates that they possess potent anti-inflammatory, cardioprotective, and neuroprotective effects. Such diverse pharmacological profiles highlight the immense potential of Aglaia-derived compounds for the development of new therapeutic drugs.
Compounds
Aglaia is a genus of traditional Chinese medicinal plants that serves as a rich natural source for potent anticancer compounds. These plants contain rocaglamide, a compound known to preferentially induce apoptosis in various human leukemia cell lines. Furthermore, Aglaia contains ROC, a term often used to refer to these rocaglamide-based derivatives that show promise in treating hematologic malignancies. The genus also contains rocaglaol, which exhibits nanomolar level antitumor activity and can be used to develop water-soluble derivatives. Together, these chemical constituents within Aglaia offer significant potential for the development of new drugs with reduced toxicity to healthy cells.
Conditions
Aglaia genus plants produce compounds like aglain and rocaglamide that effectively treat EV-A71 by suppressing its replication. These derivatives also serve as potential antiviral agents to treat HFMD. In oncological applications, Aglaia-derived compounds treat acute lymphoblastic leukemia and acute myeloid leukemia by inducing apoptosis through intrinsic death pathways. Furthermore, these substances demonstrate significant antitumor activity against various cancer cell lines. Through these diverse mechanisms, Aglaia derivatives show promise as therapeutic leads for both viral infections and hematologic malignancies.